GSSCX
Price
$15.46
Change
+$0.16 (+1.05%)
Updated
Sep 26 closing price
Net Assets
941.5M
UBVVX
Price
$86.07
Change
+$0.94 (+1.10%)
Updated
Sep 26 closing price
Net Assets
9.84B
Interact to see
Advertisement

GSSCX vs UBVVX

Header iconGSSCX vs UBVVX Comparison
Open Charts GSSCX vs UBVVXBanner chart's image
Goldman Sachs Small Cap Value C
Price$15.46
Change+$0.16 (+1.05%)
VolumeN/A
Net Assets941.5M
Undiscovered Managers Behavioral Val R5
Price$86.07
Change+$0.94 (+1.10%)
VolumeN/A
Net Assets9.84B
GSSCX vs UBVVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSSCX vs. UBVVX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSSCX is a Hold and UBVVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.84B vs. GSSCX (942M). UBVVX (1.77) and GSSCX (1.70) have matching dividends . GSSCX was incepted earlier than UBVVX: GSSCX (28 years) vs UBVVX (9 years). GSSCX (2.18) is less costly to investors than UBVVX (0.95). GSSCX is a more actively managed with annual turnover of: 83.00 vs. UBVVX (27.00). UBVVX has a lower initial minimum investment than GSSCX: UBVVX (0) vs GSSCX (1000). UBVVX annual gain was more profitable for investors over the last year : 0.31 vs. GSSCX (-28.46). UBVVX return over 5 years is better than : 107.51 vs. GSSCX (-39.88).
GSSCXUBVVXGSSCX / UBVVX
Total Expense Ratio2.000.90222%
Annual Report Gross Expense Ratio2.180.95229%
Fund Existence28 years9 years-
Gain YTD7.4362.489299%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets942M9.84B10%
Annual Yield % from dividends1.701.7796%
Returns for 1 year-28.460.31-9,254%
Returns for 3 years-36.6522.75-161%
Returns for 5 years-39.88107.51-37%
Returns for 10 years-58.05N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADAP0.150.02
+15.75%
Adaptimmune Therapeutics plc
TECX15.200.49
+3.33%
Tectonic Therapeutic Inc.
TTE63.150.73
+1.17%
TotalEnergies SE
AXTA28.090.30
+1.08%
Axalta Coating Systems Ltd
WABC50.050.38
+0.77%
Westamerica Bancorporation